The autopsy report conducted after the untimely death of IFBB Pro Dallas McCarver was released this week.
The 26-year-old bodybuilding star died on 22 August 2017 when training partner and fellow IFBB Pro Josh Lenartowicz found him on the floor in his living room after a cardio session at the gym. According to the autopsy report McCarver died due to a combination of coronary atherosclerosis (a buildup of plaque in the arteries) and an enlarged left ventricle (a thickening of the heart muscle that causes it to work harder). He had a family history of cardiovascular disease including both hypertension and atherosclerosis. Prior to his death McCarver, who suffered from asthma as a child, complained about a chronic cough and shortness of breath.
The coroner noted that McCarver’s testosterone levels were within normal range at the time of death, despite having an elevated epitestosterone level (indicating testosterone replacement, though not abuse per se).
Trenbolone metabolites were also present and he tested positive for caffeine and marijuana metabolites (neither of which are mentioned as contributing factors in his death). No other recreational drugs or narcotics were present in his body. Also noted (but neither tested for nor listed as a contributing factor in his death) was a prior history of HGH and insulin use.